Evidence map›Paper›PMID 35567290›Full record

ArticleJournal of cellular and molecular medicine2022

A possible new activator of PI3K-Huayu Qutan Recipe alleviates mitochondrial apoptosis in obesity rats with acute myocardial infarction.

He Tai, Yu-Jing Tong, Rui Yu, You Yu, Si-Cheng Yao, Ling-Bing Li, Ye Liu, Xiao-Zheng Cui, Jin-Song Kuang, Xian-Sheng Meng and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.0field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 7 institutions in 1 country.

He TaiSchool of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian, China.
Yu-Jing TongDepartment of Pediatrics, Shengjing Hospital of China Medical University, Shenyang, China.
Rui YuScience and Technology Branch, Liaoning University of Traditional Chinese Medicine, Shenyang, China.
You YuKey Laboratory of Ministry of Education for Traditional Chinese Medicine Viscera-State Theory and Applications, Liaoning University of Traditional Chinese Medicine, Shenyang, China.
Si-Cheng YaoKey Laboratory of Ministry of Education for Traditional Chinese Medicine Viscera-State Theory and Applications, Liaoning University of Traditional Chinese Medicine, Shenyang, China.
Ling-Bing LiDepartment of Graduate School, China PLA General Hospital, Beijing, China.
Ye LiuThird Affiliated Hospital of Beijing University of Chinese Medicine, Beijing, China.
Xiao-Zheng CuiCardiovascular Surgery, School of Clinical Medicine, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China.
Jin-Song KuangDepartment of Endocrinology and Metabolism, The Fourth People's Hospital of Shenyang, Shenyang, China.
Xian-Sheng MengSchool of Pharmacy, Liaoning University of Traditional Chinese Medicine, Dalian, China.
Xiao-Lin JiangKey Laboratory of Ministry of Education for Traditional Chinese Medicine Viscera-State Theory and Applications, Liaoning University of Traditional Chinese Medicine, Shenyang, China.ORCID 0000-0002-8162-0468
Liaoning University of Traditional Chinese Medicine · CNBeijing Tsinghua Chang Gung Hospital · CNBeijing University of Chinese Medicine · CNChina Medical University · CNChinese PLA General Hospital · CNGuangzhou University of Chinese Medicine · CNThe Fourth People's Hospital · CN

Funding

Liaoning Province Science and Technology Program Project-Industrial Major Project-Innovative research and development of a large variety of traditional Chinese medicine Yuxuebi preparations for the treatment of rheumatoid arthritis and heart disease 2020JH1/10100022
6 · The paper itself

Abstract

Obesity, which has unknown pathogenesis, can increase the frequency and seriousness of acute myocardial infarction (AMI). This study evaluated effect of Huayu Qutan Recipe (HQR) pretreatment on myocardial apoptosis induced by AMI by regulating mitochondrial function via PI3K/Akt/Bad pathway in rats with obesity. For in vivo experiments, 60 male rats were randomly divided into 6 groups: sham group, AMI group, AMI (obese) group, 4.5, 9.0 and 18.0 g/kg/d HQR groups. The models fed on HQR with different concentrations for 2 weeks before AMI. For in vitro experiments, the cardiomyocytes line (H9c2) was used. Cells were pretreated with palmitic acid (PA) for 24 h, then to build hypoxia model followed by HQR-containing serum for 24 h. Related indicators were also detected. In vivo, HQR can lessen pathohistological damage and apoptosis after AMI. In addition, HQR improves blood fat levels, cardiac function, inflammatory factor, the balance of oxidation and antioxidation, as well as lessen infarction in rats with obesity after AMI. Meanwhile, HQR can diminish myocardial cell death by improving mitochondrial function via PI3K/Akt/Bad pathway activation. In vitro, HQR inhibited H9c2 cells apoptosis, improved mitochondrial function and activated the PI3K/Akt/Bad pathway, but effects can be peripeteiad by LY294002. Myocardial mitochondrial dysfunction occurs following AMI and can lead to myocardial apoptosis, which can be aggravated by obesity. HQR can relieve myocardial apoptosis by improving mitochondrial function via the PI3K/Akt/Bad pathway in rats with obesity.

Indexed as

Myocardial InfarctionPhosphatidylinositol 3-KinasesAnimalsApoptosisMaleMitochondriaMyocytes, CardiacObesityProto-Oncogene Proteins c-aktRatsRats, Sprague-DawleyPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-aktacute myocardial infarctionapoptosisHuayu Qutan Recipemitochondrial dysfunctionobesityPI3K/Akt/Bad pathway

Identifiers

PMID35567290
PMCPMC9189350
OpenAlexW4280497724

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.